INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 111 filers reported holding INSMED INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $496,000 | -32.5% | 39,172 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $735,000 | +3.7% | 39,172 | -27.9% | 0.00% | 0.0% |
Q3 2014 | $709,000 | -46.5% | 54,324 | -28.0% | 0.00% | -50.0% |
Q2 2014 | $1,325,000 | -30.0% | 75,428 | -36.8% | 0.00% | -33.3% |
Q1 2014 | $1,892,000 | -3.1% | 119,254 | +25.7% | 0.00% | -25.0% |
Q4 2013 | $1,952,000 | +9.5% | 94,879 | -16.9% | 0.00% | +33.3% |
Q3 2013 | $1,782,000 | +24.1% | 114,150 | -5.0% | 0.00% | 0.0% |
Q2 2013 | $1,436,000 | – | 120,115 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |